WO2000028010A3 - Die gentechnische prägung von zellen und ihre verwendung zur prophylaxe und therapie von erkrankungen - Google Patents
Die gentechnische prägung von zellen und ihre verwendung zur prophylaxe und therapie von erkrankungen Download PDFInfo
- Publication number
- WO2000028010A3 WO2000028010A3 PCT/EP1999/007902 EP9907902W WO0028010A3 WO 2000028010 A3 WO2000028010 A3 WO 2000028010A3 EP 9907902 W EP9907902 W EP 9907902W WO 0028010 A3 WO0028010 A3 WO 0028010A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cells
- diseases
- prophylaxis
- genes
- therapy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/069—Vascular Endothelial cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/165—Vascular endothelial growth factor [VEGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/11—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Communicable Diseases (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cell Biology (AREA)
- Hospice & Palliative Care (AREA)
- Microbiology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU10407/00A AU1040700A (en) | 1998-11-05 | 1999-10-19 | The genetic determination of genes and its use for the prophylaxis and therapy of diseases |
EP99953880A EP1127109A2 (de) | 1998-11-05 | 1999-10-19 | Die gentechnische prägung von zellen und ihre verwendung zur prophylaxe und therapie von erkrankungen |
CA002349497A CA2349497A1 (en) | 1998-11-05 | 1999-10-19 | The genetic determination of genes and its use for the prophylaxis and therapy of diseases |
JP2000581177A JP2002529080A (ja) | 1998-11-05 | 1999-10-19 | 細胞の遺伝子マーキングならびに疾病の予防および治療のためのその使用 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19850986.3 | 1998-11-05 | ||
DE19850986A DE19850986A1 (de) | 1998-11-05 | 1998-11-05 | Die gentechnische Prägung von Zellen und ihre Verwendung zur Prophylaxe und Therapie von Erkrankungen |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000028010A2 WO2000028010A2 (de) | 2000-05-18 |
WO2000028010A3 true WO2000028010A3 (de) | 2000-07-27 |
Family
ID=7886784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1999/007902 WO2000028010A2 (de) | 1998-11-05 | 1999-10-19 | Die gentechnische prägung von zellen und ihre verwendung zur prophylaxe und therapie von erkrankungen |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1127109A2 (de) |
JP (1) | JP2002529080A (de) |
AU (1) | AU1040700A (de) |
CA (1) | CA2349497A1 (de) |
DE (1) | DE19850986A1 (de) |
WO (1) | WO2000028010A2 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0015761D0 (en) * | 2000-06-27 | 2000-08-16 | Univ Bristol | Polypeptide |
US6962982B2 (en) | 2001-06-22 | 2005-11-08 | Roche Diagnostics Corporation | Soluble complexes of target proteins and peptidyl prolyl isomerase chaperones and methods of making and using them |
DE10158680B4 (de) * | 2001-11-30 | 2004-04-08 | Universitätsklinikum Hamburg-Eppendorf | Verfahren zur ex vivo-Expansion und -Differenzierung von multipotenten Stammzellen |
FR3018819A1 (fr) * | 2014-03-19 | 2015-09-25 | Univ Bourgogne | Traitement de la reponse inflammatoire et dysimmunitaire |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998019712A1 (en) * | 1996-11-08 | 1998-05-14 | St. Elizabeth's Medical Center Of Boston, Inc. | Methods for regulating angiogenesis |
WO1998039427A2 (en) * | 1997-03-06 | 1998-09-11 | University Of Massachusetts | Gene therapy using bone marrow transplants transfected with therapeutic genes under the control of tissue-specific promoters |
-
1998
- 1998-11-05 DE DE19850986A patent/DE19850986A1/de not_active Withdrawn
-
1999
- 1999-10-19 AU AU10407/00A patent/AU1040700A/en not_active Abandoned
- 1999-10-19 EP EP99953880A patent/EP1127109A2/de not_active Withdrawn
- 1999-10-19 CA CA002349497A patent/CA2349497A1/en not_active Abandoned
- 1999-10-19 JP JP2000581177A patent/JP2002529080A/ja not_active Withdrawn
- 1999-10-19 WO PCT/EP1999/007902 patent/WO2000028010A2/de not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998019712A1 (en) * | 1996-11-08 | 1998-05-14 | St. Elizabeth's Medical Center Of Boston, Inc. | Methods for regulating angiogenesis |
WO1998039427A2 (en) * | 1997-03-06 | 1998-09-11 | University Of Massachusetts | Gene therapy using bone marrow transplants transfected with therapeutic genes under the control of tissue-specific promoters |
Non-Patent Citations (2)
Title |
---|
ASAHARA T ET AL: "ISOLATION OF PUTATIVE PROGENITOR ENDOTHELIAL CELLS FOR ANGIOGENESIS", SCIENCE,US,AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, vol. 275, 14 February 1997 (1997-02-14), pages 964 - 967, XP002059361, ISSN: 0036-8075 * |
HAVEMANN K ET AL: "Generation of endothelial cells from CD34/CD14-positive mononuclear cells of human peripheral blood.", 89TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH;NEW ORLEANS, LOUISIANA, USA; MARCH 28-APRIL 1, 1998, vol. 39, March 1998 (1998-03-01), Proceedings of the American Association for Cancer Research Annual Meeting March, 1998, pages 61, XP002135753, ISSN: 0197-016X * |
Also Published As
Publication number | Publication date |
---|---|
AU1040700A (en) | 2000-05-29 |
JP2002529080A (ja) | 2002-09-10 |
DE19850986A1 (de) | 2000-05-25 |
EP1127109A2 (de) | 2001-08-29 |
CA2349497A1 (en) | 2000-05-18 |
WO2000028010A2 (de) | 2000-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002102997A3 (en) | Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same | |
IL192078A0 (en) | Recombinant ??-l-iduronidase,methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof | |
WO1998011243A3 (en) | Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein | |
NZ507103A (en) | Cell differentiation/proliferation and maintenance factor and uses thereof | |
WO2004003182A3 (en) | Homozygous stem cells isolated from pathogenic oocytes | |
MX9705039A (es) | Genes y proteinas de muerte celular programada. | |
CA2098849A1 (en) | Control of gene expression by ionizing radiation | |
AU6989094A (en) | Compositions and methods for treating cancer and hyperproliferative disorders | |
CA2155024A1 (en) | Genetic Modification of Neural Stem Cells | |
MY134810A (en) | Targeted gene expression of thrombopoietein, dnase i and b-interferon | |
AU2790292A (en) | Viral recombinant vectors for expression in muscle cells | |
HU905679D0 (en) | Process for producing new units suitable for treating cancerous illnesses and pharmaceutical preparatives containing them | |
CA2257077A1 (en) | Treatment of diarrhea | |
EP0568537A4 (de) | Genetische veränderung von endothelzellen. | |
EP0266190A3 (en) | Expression of protein c | |
WO2003018782A3 (en) | Differentiation of neural stem cells and therapeutic use theeof | |
AU5455386A (en) | Neovascularization inhibitors and methods for their production and use | |
DE60030324D1 (de) | Replikationsunfähige herpesviren zur verwendung in gentherapie | |
CA2253287A1 (en) | A process for producing a recombinant polypeptide involving the addition of an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium | |
EP1616960A3 (de) | Menschliche Pancreas Zellinien: Entwicklungen und Anwendungen | |
WO2003025151A3 (en) | Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression | |
KR920004570A (ko) | 사람 mk 단백질을 암호하는 유전자, 이를 포함하는 발현 벡터 및 숙주 세포, mk단백질의 생산 방법 및 사용방법 | |
WO2000028010A3 (de) | Die gentechnische prägung von zellen und ihre verwendung zur prophylaxe und therapie von erkrankungen | |
HUP0002317A2 (hu) | Gyulladásos sejtek önszabályzott apoptózisa génterápiával | |
AU3824893A (en) | Process for production of exogenous gene or its product in plant cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref country code: AU Ref document number: 2000 10407 Kind code of ref document: A Format of ref document f/p: F |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999953880 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 581177 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref document number: 2349497 Country of ref document: CA Ref country code: CA Ref document number: 2349497 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 1999953880 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999953880 Country of ref document: EP |